(Q46594092)

English

Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial

scientific article published in August 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

multicenter clinical trial

1 reference

based on heuristic

inferred from title

4

object named as

Dirk Kuypers

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

author name string

Daniel Abramowicz

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Yves Vanrenterghem

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Jean-Paul Squifflet

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Michel Mourad

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Michel Meurisse

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Martin Wissing

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Clinical Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

19

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

475-482

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Mechanism of cyclosporine-induced hypertension

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Posttransplant diabetes mellitus in kidney allograft recipients: incidence, risk factors, and management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Randomized double-blind study of immunoprophylaxis with basiliximab, a chimeric anti-interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil-containing triple therapy in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

The impact of impaired insulin release and insulin resistance on glucose intolerance after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00369.X

21 January 2018

Identifiers

10.1111/J.1399-0012.2005.00369.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/16008591

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46594092&oldid=2121246009"